Welcome to Targanta Therapeutics Printer Friendly Version

Margaret Wasilewski, M.D.
Vice President, Clinical Development

Margaret Wasilewski, M.D. has served as Vice President, Clinical Development at Targanta since January 2006. From 2003 to January 2006, Dr. Wasilewski was the President of ID Remedies LLC, a pharmaceutical drug development consulting company. From 1996 to 2003, Dr. Wasilewski held various positions at Lilly, most recently as Senior Clinical Research Physician, Infectious Disease and Oritavancin Product Team Lead Physician. Dr. Wasilewski received an M.D. from Tufts University and is board certified in Infectious Diseases and Internal Medicine. Dr. Wasilewski also received a M.S. in Nutrition from the University of California, Berkeley and a B.A. in Chemistry from Douglass College.